These data imply that GLP-1 analogues such as liraglutide are an effective treatment option for South Asian patients with type 2 diabetes that might improve glycaemic control by reducing visceral adipose tissue volume. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.